OS Therapies

OSTX | AMEX

Price Alert Chart Builder DCF Calculator

$1.74

-$0.03 (-1.69%)

At close: Sep 21, 2026, 4:00 PM ET

$1.78

+$0.04 (+2.29%)

Pre-market: Sep 22, 2026, 9:03 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.69%

(1D)

Rating

Updated: Aug 11, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $79.24M

1D Range

1.74 1.82

52W Range

1.15 2.25

Valuation (TTM)

PE -1.60

PB -7.31

EV/EBITDA 0.01

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target $16.50

Cash Flow

FCF Yield -10.7%

SBC Adj. FCF Yield -5392.2%

SBC Impact -50544.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -58.0% | -30.8%

FCF 3Y | 5Y -32.6% | -99.8%

Returns

ROA -397.8%

ROE 683.0%

ROIC 350.1%

Financial Health

Net Cash

$205.04M

Current Ratio 0.18

Interest Coverage -464.76

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the Un...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date Jul 31, 2024

Website ostherapies.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 13, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$16.50

Upside

+848.28%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞